Chatbots have emerged as valuable tools in the realm of digital health. While off-the-shelf AI models like Open’s AI’s ChatGPT, offer impressive capabilities, their usage should be approached with caution.
MEMOTEXT co-created solutions featured in 3 peer-reviewed publications in 2023! At MEMOTEXT we pride ourselves in co-creating and validating digital patient engagement communications and digital therapeutics (DTx) with our partners.
Digital health technologies have become a promising way to identify, assess and treat mental health conditions. These technologies have the potential to address many of the existing barriers that accompany
Working with our provider, academic and clinical, pharmacy and employer clients, we have been learning and capturing best practices in digital patient engagement. Here’s a sneak peek at our top
To enhance access to varied mental health support within a stepped care model, Georgian’s Mental Health and Well-being (MHWB) team worked with MEMOTEXT to co-design elements of a digital live-chat
Jan 26, 2023 (Toronto, ON) – MEMOTEXT Corp., North America’s leading platform for digital patient engagement co-creation has partnered with the Centre for Addiction and Mental Health (CAMH) with help
Led by Elders of Syilx Nation and in collaboration with Interior Health Authority, a research team, and community service providers, MEMOTEXT is developing an app based on the SmartParent program
Toronto, October 31, 2022 – MEMOTEXT Corporation and Vanderbilt University Medical Center (VUMC) have successfully reached an agreement to make the Rapid Education And Communications for Health (REACH) text messaging
Amos Adler and Dr. Sean Kidd had an amazing opportunity to sit down with the BetaKit podcast to discuss digital therapeutics and where A4i fits in in the current healthcare
A4i is proud to announce the extension of the Help@Hand A4i pilot program with Riverside University Health System – Behavioral Health. The pilot program utilizes A4i to support clients, care
Mental health struggles are at an all-time high due to the impacts of COVID-19. Whether it was due to social isolation, financial burden, grief, or other factors, we continue to
Toronto March 2022, MEMOTEXT Corporation, Canada’s leading platform for the development, validation and commercialization of digital patient engagement communications announces a new collaboration with the University of Saskatchewan and the
We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.
Get updates on new products, projects and stay on top of all things MEMOTEXT.